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Abstract
Guillain-Barré syndrome (GBS) has been associated with both infective or non-infective aetiologies. GBS is usually 
preceded by acute respiratory or gastrointestinal infection but its association with tuberculosis has been exceptionally 
reported. Inflammatory bowel disease (IBD) is associated with clinical manifestations involving the neurological system, 
peripheral neuropathy is known to be related to IBD and, either demyelinating or axonal involvement of peripheral 
nerves have been described. We report an unusual case of GBS associated with lymph node tuberculosis and ulcerative 
colitis.
Background
Guillain-Barré syndrome (GBS) is an acquired inflamma-
tory peripheral neuropathy defined by acute onset, cere-
brospinal fluid (CSF) albumin cytological dissociation
and a clinical monophasic course with partial or total
recovery. Most evidences support the hypothesis of an
autoimmune origin, with cellular and humoral immunity
working together against an aggressive agent. In 60% of
cases, the onset is preceded by acute respiratory or gas-
trointestinal tract infection, although in most of the cases
it is not possible to know the causal agent [1].
Peripheral neuropathy is known to be related to inflam-
matory bowel disorders (IBD) and is one of the most fre-
quently reported neurologic complications.
Demyelinating or axonal involvement of peripheral
nerves in IBD have been described, and both neuropa-
thies could be acute or chronic. On the one hand, acute
and chronic demyelinating inflammatory polyneuropathy
has been reported, as well as multifocal motor neuropa-
thy; on the other hand, mononeuritis multiple and large-
and small-fibre axonal neuropathy have been also found
[2-5].
Neuropathies in association with tuberculosis (TB)
infections are uncommon but have been previously
reported to occur due to associated malnutrition, alco-
holism, and the neuropathic effects of medication [6].
However, association of GBS and TB has been reported
[7-11], moreover, in a recent report, Soysal y Cols., found
2 out of 104 cases of GBS to be associated with TB [12].
We report an unusual case of GBS with a multiple asso-
ciation. The patient was diagnosed with lymph node
tuberculosis (LNT) and suffered GBS early after treat-
ment onset. Later, in the evolutionary course he pre-
sented an outbreak of ulcerative colitis (UC) previously
unknown. In our knowledge, this very unusual associa-
tion has never been described.
Case Presentation
A 74 year old man was seen as an outpatient in the Hae-
matology Division after finding macrocytosis on a usual
complete blood count (CBC). His previous clinical his-
tory had been unremarkable. During the physical exami-
nation, vital signs were normal, cervical adenopathy was
palpable and body mass index was 20 kg/m2. A CBC test
showed monocytosis, reticulocyte count was normal and
direct Coombs was negative. Bone marrow aspirate was
hypercellular with appropriate haematopoietic respon-
siveness without dysplastic expression and a normal
myeloerythroid ratio; in erythroid series giant forms were
observed; in myeloid series cytoplasmatic degranulation
and pseudo Pelger-Huet forms with low increase in
myelocites and moderate increase of monocytes count
were found; no cellular niches were seen. Biochemical
test panel was irrelevant. Serological tests for cytomega-
lovirus, toxoplasmosis, syphilis, Epstein-Barr virus,
human immunodeficiency virus and type A, B & C hepa-
titis virus were negative. The tuberculin test was reactive
in 5 mm. The cervical fine needle aspirate was negative
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for malignancy and diagnosed for lymphadenitis, a path-
ological specimen showed extensive necrotic inflamma-
tion with caseum aspect; microscopic examination
revealed multiple epithelioid cells, granulomas and multi-
nucleated giant cells, and extensive central necrosis;
chronic lymphocytic infiltrate and fibrosis, plasma cells
and histiocytes were seen in the periphery. These features
were related to the diagnosis of LNT. Sputum and urine
smears were negative in two results; lymph node culture
was positive for mycobacterium tuberculosis, with nor-
mal susceptibility to usual drugs. No abnormalities were
depicted in chest radiograph. The patient was given iso-
niazid (300 mg daily), rifampicin (600 mg daily), and
pyrazinamide (1200 mg daily).
Six days later, the patient suffered acute and progressive
legs weakness that ascended to the arms in the first 24
hours, without sensory loss. A lumbar puncture showed
normal protein at 0.36 g/L without pleocytosis. CSF
smear was normal. Genomic study and culture for myco-
bacterium tuberculosis were negative as well as cytologi-
cal CSF. Cranial computer tomography showed non-
specific brain atrophy. Neurophysiological study was con-
sistent with motor axonal polyneuropathy without evi-
dence of acute denervation (Table 1). Antibodies to
nuclear antigens were negative, as well as genomic test for
Lyme and Campylobacter jejuni. Urine levels of uro/
coproporphyrins were not increased. Antibodies binding
gangliosides IgM class GM-1, GDA-1 and GM-2 were
positive. Intravenous immunoglobulin therapy was given
as 0.4 g/kg over 5 days, with slow neurological recovery.
Two months later the patient suffered an enteric diar-
rhoea with bloody stool, fever and abdominal pain. Stool
cultures for bacterial pathogens and serologic tests for
amebiasis were negative. An endoscopic view of the colon
showed friable mucosa, extensive ulceration and exu-
dates. Pathological findings at colon and rectum biopsies
consisted of neutrophils in mucosa and submucosa, neu-
trophil clumps in crypt lumen (crypt abscesses), mucosal
edema and vascular congestion with focal haemorrhage.
Aminosaclicylates were given to the patient who experi-
enced partial clinical improvement.
Discussion
Peripheral neuropathies in association with TB infection
are very uncommon reported except polyneuropathy
related to isoniazid and ethanbutol toxicity, apart from
these toxic forms, reports are in form of acute or chronic
demyelinizanting polyneuropathy [6]. The exact patho-
genesis of SGB associated with TB remains obscure but it
is believed to be due to a molecular mimicry leading to
the immunological attack of peripheral nerves. This con-
cept of molecular mimicry is further supported by studies
showing clinical improvement after receiving immuno-
modulatory agents. In addition, direct involvement of the
Table 1: Patient neurophysiological data.
RMN LMN RUN
RV NV RV NV RV NV
DL 4.4 ms > 4.6 ms DL 4.1 ms < 4.6 ms DL 5.9 ms < 4.2 ms
MAP 2 mV > 8 mV MAP 1 mV > 8 mV MAP 1.5 mV > 7 mV
SCV 53 m/s > 43 m/s SCV 51 m/s > 43 m/s SCV 45 m/s > 45 m/s
SAP 5 μV > 36 μV SAP 8 μV > 36 μV SAP 12 μV > 32 μV
LR ND
EMG
RAPB N RADM N
RMN: right median nerve; LMN: left median nerve; RUN: right ulnar nerve; RV: recorded values; NV: normal values; DL: distal latency; MAP: 
muscular amplitude potential; SCV: sensory conduction velocity; SAP: sensory amplitude potential; LR: late responses; ND: not detectable; 
EMG: electromyographic features; RAPB: right abductor pollicis brevis muscle; RADM: right abductor digiti minimi; N: no pathological 
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peripheral nervous system has been reported as a result
of meningeal involvement, direct nerve root involvement,
and granuloma affecting peripheral nerves [8-10].
Although UC and Crohn's disease (CD) have been tra-
ditionally considered limited to the gastrointestinal tract,
it is known that numerous extraintestinal manifestations
(EM) affect many systems. Prevalence is high, EM related
with IBD appeared at least once in 46.6% of the patients.
EM are lightly more frequent in CD than UC and their
rate increases with their evolution. Although rare, neuro-
logical complications can be very serious and irreversible
without an initial appropriate treatment. Little is known
about neurological EM prevalence, but 20-30% has been
reported, some cases preceding IBD and some being
diagnosed after their remission [13-15]. Several patho-
genic mechanisms have been suggested to explain the
affectation of peripheral and central nervous system by
IBD: malabsorption, deficiency of vitamins, formations of
toxic agents, direct effects of the treatment (infections,
complications of the immunosuppression), thromboem-
bolism disease and immunological problems [13,14].
Peripheral neuropathies related to IBD seems to be more
frequent in UC, with a reported incidence of 1,9%. How-
ever, it seems that UC presents a lower rate of demyeli-
nating forms as compared to CD. The treatment of these
patients is controversial but some cases of good evolution
are described with corticosteroids and 5-aminosalicylic
acid [13-16].
The neurophysiological study of our patient showed an
acute axonal motor neuropathy subtype of GBS in spite of
normal CSF protein level because elevated CSF protein
may not be apparent in the first 7 to 10 days of the acute
illness in up to 10% cases of GBS [1]. GBS developed after
the treatment of TB started, therefore GBS might be asso-
ciated with TB rather than UC, although disturbances in
the immune system due to UC played a role on the devel-
opment of GBS. This neurological complication is inter-
preted in terms of a paradoxical disease expansion during
antituberculous therapy without drug resistance [10].
This situation appears after initiating treatment in a local
expansion form or in a systemic dissemination to other
systems, mainly nervous system and skin. The antigens
production mechanism would be caused by the liberation
of tuberculosis bacillus proteins or by the liberation of
cytokines, mainly tumour necrosis factor alpha, both
related to the action of tuberculosis treatment [10].
Conclusion
We present a case of GBS occurring in association with
LNT and IBD. Descriptions of association between TB
and GBS have been reported but this unique disorder
combination has seldom been described. We suggest that
GBS may be related to the preexisting chronic IBD and
m a y  b e  r e g a r d e d  a s  a  p o s s i b l e  E M  o f  U C .  A s  s o m e
patients with GBS also present an infectious antecedent,
the coincidental LNT may play a role in the pathogenesis
of GBS. Our case highlights the need to considerer TB in
patients with GBS.
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